Our research further confirms the detrimental impacts of elevated levels of RHBDF2 and TNFRSF10B in the development of AD, linking them to immune cells, especially microglia, providing a new research direction for these factors in exacerbating AD pathology through mediating immune dysregulation. The gene discussed is TNFRSF10B; the disease is Alzheimer disease.